Diet, lifestyle, and colorectal cancer: Is hyperinsulinemia the missing link?

Nutrition Reviews

Volumn 56, Issue 9, 1998, Pages 275-279

  Kim, Young In ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ALCOHOL CONSUMPTION; CANCER RISK; COLORECTAL CANCER; DIABETES MELLITUS; DIETARY INTAKE; HUMAN; HYPERINSULINEMIA; HYPOTHESIS; INSULIN RESISTANCE; LIFESTYLE; OBESITY; PHYSICAL ACTIVITY; SHORT SURVEY;

EID: 0031695628     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.1998.tb01765.x     Document Type: Short Survey

References (39)

1. Anon. Cancer facts and figures: 1998. Atlanta, GA: American Cancer Society, 1998
2. Kim YI, Mason JB. Nutrition chemoprevention of gastrointestinal cancers: a critical review. Nutr Rev 1996;54:259-79
3. Potter JD, Slattery ML, Bostick RM, Gapstur SM. Colon cancer: a review of the epidemiology. Epidemiol Rev 1993;15:499-545
4. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981;66:1191-308
5. Helisouer KJ, Block G, Blumberg J, et al. Summary of the round table discussion on strategies for cancer prevention: diet, food, additives, supplements, and drugs. Cancer Res 1994;54(suppl):2044S-51S
6. Schatzkin A, Lanza E, Freedman LS, et al. The Polyp Prevention Trial I: rationale, design, recruitment, and baseline participant characteristics. Cancer Epidemiol Biomarkers Prev 1996;5:375-83
7. Lanza E, Schatzkin A, Ballard-Barbash R, et al. The Polyp Prevention Trial II: dietary intervention program and participant baseline dietary characteristics. Cancer Epidemiol Biomarkers Prev 1996;5:385-92
8. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 1994;3:687-95
9. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995;6:164-79
10. Watkins LF, Lewis LR, Levine AE. Characterization of the synergistic effects of insulin and transferrin and the regulation of their receptors on a human colon carcinoma cell line. Int J Cancer 1990;45:372-5
11. Bjork J, Nilsson J, Hultcrantz R, Johnasson C. Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the nontransformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29. Scand J Gastroenterol 1993;28:879-84
12. + glucose transport across the brush border. J Recept Res 1993;13:1093-113
13. Guo YS, Narayan S, Yallampalli C, Singh R Characterization of insulin-like growth factor I receptors in human colon cancer. Gastroenterology 1992;102:1101-8
14. Macaulay VM. Insulin-like growth factors and cancer. Br J Cancer 1992;65:311-20
15. Cullen KJ, Yee D, Rosen N. Insulin-like growth factors in human malignancy. Cancer Invest 1991;9:443-54
16. Culouscou JM, Shoyah M. Purification of a colon cancer cell growth inhibitor and its identification as an insulin-like growth factor binding protein. Cancer Res 1991;51:2813-9
17. Ritter MM, Richter WO, Schwandt R Acromegaly and colon cancer. Ann Intern Med 1987;106:636-7
18. Williams JC, Walsh DA, Jackson JF. Colon carcinoma and diabetes mellitus. Cancer 1984;54:3070-1
19. O'Mara BA, Byers T, Schoenfeld E. Diabetes mellitus and cancer risk: a multisite case-control study. J Chron Dis 1985;38:435-41
20. Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations, and medications: case-control results from the Melbourne Colorectal Cancer Study. Cancer Res 1988;48.4399-404
21. La Vecchia C, D'Avanzo B, Negri E, Franceschi S. History of selected diseases and the risk of colorectal cancer. Eur J Cancer 1991;27:582-6
22. La Vecchia C, Negri E, Franceschi S, et al. A case-control study of diabetes mellitus and cancer risk. Br J Cancer 1994;70:950-3
23. La Vecchia C, Negri E, Decarli A, Franceschi S. Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1997;6:1007-10
24. Le Marchand L, Wilkens LR, Kolonel LN, et al. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res 1997;57:4787-94
25. Kessler II. Cancer mortality among diabetics. J Natl Cancer Inst 1970;44:673-86
26. Ragozzino M, Melton LJ III, Chu C-P Palumbo PJ. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chron Dis 1982;35:13-9
27. Jensen OM, Green A. Frequency of cancer among insulin-treated diabetic patients in Denmark. Diabetologia 1985;28:128-30
28. Adami HO, McLaughlin MJ, Ekbom A, et al. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991;2:307-14
29. Steenland K, Nowlin S, Palu S. Cancer incidence in the National Health and Nutrition Examination Survey I follow-up data: diabetes, cholesterol, pulse, and physical activity. Cancer Epidemiol Biomarkers Prev 1995;4:807-11
30. Levine W, Dyer AR, Shekelle RB, et al. Post-load plasma glucose and cancer mortality in middle-aged men and women: 12-year follow-up findings of the Chicago Heart Association Detection Project in Industry. Am J Epidemiol 1990;131:254-62
31. Smith GD, Egger M, Shipley MJ, Marmot MG. Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men. Am J Epidemiol 1992;136:1110-4
32. Weiderpass E, Gridley G, Nyren O, et al. Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst 1997;89:660-1
33. Will JC, Galuska DA, Vinicor F, Calle EE. Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol 1998;147:816-25
34. Harris MI, Hadden WC, Knowler WC, et al. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74 years. Diabetes 1987;36:523-34
35. Tomasi F, Pareschi PL. Screening for diabetes mellitus. In: Morsiani M, ed. Epidemiology and screening of diabetes. Boca Raton, FL: CRC Press, 1989;53-67
36. Tran TT, Medline A, Bruce WR. Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev 1997;5:1013-5
37. Corpet DE, Jacquinet C, Peiffer G, Tache S. Insulin injections promote the growth of aberrant crypt foci in the colon of rats. Nutr Cancer 1997;27:316-20
38. Bird RP Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 1995;93:55-71
39. Koohestani N, Tran TT, Lee W, et al. Insulin resistance and promotion of aberrant crypt foci in the colons of rats on a high-fat diet. Nutr Cancer 1997;29:69-76